Shares of Spire Healthcare Group PLC (LON:SPI) have earned an average rating of “Hold” from the eight analysts that are presently covering the company. Five investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is GBX 372.50 ($4.61).
Several brokerages have weighed in on SPI. Jefferies Group restated a “hold” rating and set a GBX 335 ($4.15) price target on shares of Spire Healthcare Group PLC in a report on Monday, August 8th. Numis Securities Ltd restated an “add” rating and set a GBX 360 ($4.46) price target on shares of Spire Healthcare Group PLC in a report on Thursday, August 25th. Berenberg Bank restated a “buy” rating and set a GBX 395 ($4.89) price target on shares of Spire Healthcare Group PLC in a report on Friday, September 9th. JPMorgan Chase & Co. restated a “neutral” rating and set a GBX 433 ($5.36) price target on shares of Spire Healthcare Group PLC in a report on Friday, July 15th. Finally, Barclays PLC restated an “overweight” rating and set a GBX 382 ($4.73) price target on shares of Spire Healthcare Group PLC in a report on Friday, August 26th.
Shares of Spire Healthcare Group PLC (LON:SPI) traded up 0.13% during midday trading on Monday, reaching GBX 389.80. The company’s stock had a trading volume of 373,133 shares. Spire Healthcare Group PLC has a 12-month low of GBX 275.00 and a 12-month high of GBX 411.00. The company’s market cap is GBX 1.56 billion. The stock’s 50-day moving average price is GBX 371.72 and its 200-day moving average price is GBX 346.73.
The company also recently announced a dividend, which will be paid on Tuesday, December 13th. Investors of record on Thursday, November 17th will be given a GBX 1.30 ($0.02) dividend. The ex-dividend date of this dividend is Thursday, November 17th. This represents a dividend yield of 0.37%.
In other news, insider Gildersleeve,John bought 57,300 shares of the firm’s stock in a transaction that occurred on Wednesday, September 21st. The stock was purchased at an average cost of GBX 390 ($4.83) per share, with a total value of £223,470 ($276,571.78). Also, insider Gordon,Simon sold 92,174 shares of the company’s stock in a transaction dated Tuesday, August 30th. The shares were sold at an average price of GBX 350 ($4.33), for a total value of £322,609 ($399,268.56).
Spire Healthcare Group PLC Company Profile
Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.
Receive News & Ratings for Spire Healthcare Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.